← Evidence map

ArticleHematology. American Society of Hematology. Education Program2019

What to do with minimal residual disease testing in myeloma.

Elisabet E ManasanchPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31808833